<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180705040356N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-19</date_registration>
      <primary_sponsor>Tehran University of Science and Culture</primary_sponsor>
      <public_title>Compiling  of metacognitive analytical therapy protocol using intervention mapping and its effect on ego strength and reducing anxiety and depression of nurses involved with covid -19</public_title>
      <acronym></acronym>
      <scientific_title>Compiling  of metacognitive analytical therapy protocol using intervention mapping and its effect on ego strength and reducing anxiety and depression of nurses involved with covid -19</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>3</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61317</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Health service research, Other design features: One type of intervention will be conducted on three groups of one person with mild, moderate and severe anxiety and depression.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Mixed anxiety and depressive disorder.</hc_freetext>
      <i_freetext>Intervention group: Three people with the diagnosis of mild, moderate and severe anxiety and depression will be selected and a detailed discussion will be conducted regarding the objectives of the research and a baseline test will be performed until the scores of the dependent variables are stable. Then metacognitive analytic treatment intervention is performed. During the intervention for each participant, after each treatment session (before the start of the next session), the test will be administered. After the end of the intervention, the last test will be taken with a maximum interval of one week..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The research results will be available after publication.

When:
The data will be available from March 2024

To whom:
researchers

Conditions:
For therapeutic and research purposes

Where to obtain:
Science and Culture University Library

How to obtain:
By referring to the library of the University of Science and Culture and submitting a request regarding the research results

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Soleimani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran University of Science and Culture- Bahar Street - Shahid Qomoshi Street- Ashrafi Esfahani Boulevard.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۶۱۹۶۸۱۵۱</zip>
        <telephone>+98 21 4423 8171</telephone>
        <email>alisoleimani42@yahoo.com</email>
        <affiliation>Tehran University of Science and Culture</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rahim Shahbakhsh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran University of Science and Culture- Bahar Street - Shahid Qomoshi Street- Ashrafi Esfahani Boulevard.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۶۱۹۶۸۱۵۱</zip>
        <telephone>+98 21 4423 8171</telephone>
        <email>rahimshabakhsh@gmail.com</email>
        <affiliation>Tehran University of Science and Culture</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having at least a bachelor's degree in nursing
Having at least one year of work experience in different departments of Zahedan hospitals
Having satisfaction and willingness to cooperate
Being at least 23 years old and at most 30 years old
Failure to report any other severe physical or psychological illness at the initial screening interview
Not using the psychological services of another person at the same time
Having a low score and a maximum of 40% of my ability questionnaire score
being female</inclusion_criteria>
      <agemin>23 years</agemin>
      <agemax>30 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Anxiety and depression with psychotic features
Severe disability in one of the five senses
Severe mood swings</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mixed anxiety and depressive disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Three people with the diagnosis of mild, moderate and severe anxiety and depression will be selected and a detailed discussion will be conducted regarding the objectives of the research and a baseline test will be performed until the scores of the dependent variables are stable. Then metacognitive analytic treatment intervention is performed. During the intervention for each participant, after each treatment session (before the start of the next session), the test will be administered. After the end of the intervention, the last test will be taken with a maximum interval of one week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Increase Ego strength score. Timepoint: 7، 14، 21، 28، 35، 42، 49، 56، 62، 69، 75. Method of measurement: Makström Ego Strength Questionnaire.</prim_outcome>
      <prim_outcome>Decreased anxiety score. Timepoint: 7، 14، 21، 28، 35، 42، 49، 56، 62، 69، 75. Method of measurement: Beck anxiety questionnaire.</prim_outcome>
      <prim_outcome>Decreasing the depression score. Timepoint: 7، 14، 21، 28، 35، 42، 49، 56، 62، 69، 75. Method of measurement: Beck depression questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Increase my strength score. Timepoint: One week after each treatment session and one hour before the next treatment session, measurement will be done, which will be done eleven times in the process of implementing the protocol. Method of measurement: Makström Ego Strength Questionnaire.</sec_outcome>
      <sec_outcome>Decreased anxiety score. Timepoint: One week after each treatment session and one hour before the next treatment session, measurement will be done, which will be done eleven times in the process of implementing the protocol. Method of measurement: Beck anxiety questionnaire.</sec_outcome>
      <sec_outcome>Decreasing the depression score. Timepoint: One week after each treatment session and one hour before the next treatment session, measurement will be done, which will be done eleven times in the process of implementing the protocol. Method of measurement: Beck depression questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Science and Culture</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-04-12</approval_date>
        <contact_name>Royan Research Institute - Academic Jihad</contact_name>
        <contact_address>Royan Research Institute- NO  9- UNIT 10- Royan Alley- Hafez East St-Bani Hashem St- Resalat Highway- Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
